, from empty, pale grey, light grey, dark grey and black, respectively)

, Brackets and asterisk indicate significant differences (P <0.05) between levels of antibody responses in different age groups. References 1. WHO: World Malaria Report. Geneva: World Health Organization, 2013.

H. Bouharoun-tayoun, P. Attanath, A. Sabchareon, T. Chongsuphajaisiddhi, and P. Druilhe, Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes, J Exp Med, vol.172, pp.1633-1641, 1990.

S. Cohen, M. Gregor, I. Carrington, and S. , Gamma-globulin and acquired immunity to human malaria, Nature, vol.192, pp.733-737, 1961.

E. M. Riley and V. A. Stewart, Immune mechanisms in malaria: new insights in vaccine development, Nat Med, vol.19, pp.168-178, 2013.

F. J. Fowkes, J. S. Richards, J. A. Simpson, and J. G. Beeson, The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: a systematic review and meta-analysis, PLoS Med, vol.7, p.1000218, 2010.

R. Perraut, L. Marrama, B. Diouf, C. Sokhna, A. Tall et al., Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village, J Infect Dis, vol.191, pp.264-271, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-00494323

A. Toure-balde, B. L. Perlaza, J. P. Sauzet, M. Ndiaye, G. Aribot et al., Evidence for multiple B-and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3, Infect Immun, vol.77, pp.1189-1196, 2009.

J. S. Richards, T. U. Arumugam, L. Reiling, J. Healer, A. N. Hodder et al., Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development, J Immunol, vol.191, pp.795-809, 2013.

J. J. Campo, C. Dobano, J. Sacarlal, C. Guinovart, A. Mayor et al., Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens, PLoS ONE, vol.6, p.25779, 2011.

E. Baum, K. Badu, D. M. Molina, X. Liang, P. L. Felgner et al., Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenyan highland sites with differing transmission levels, PLoS ONE, vol.8, p.82246, 2013.

C. Crosnier, M. Wanaguru, B. Mcdade, F. H. Osier, K. Marsh et al., A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins, Mol Cell Proteomics, vol.12, pp.3976-3986, 2013.

F. K. Parekh and T. L. Richie, Characterization of immune reactivity profiles using microarray technology may expedite identification of candidate antigens for next generation malaria vaccines, Clin Chem, vol.53, pp.1183-1185, 2007.

E. Ambrosino, C. Dumoulin, E. Orlandi-pradines, F. Remoue, A. Toure-balde et al., A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens, Malar J, vol.9, p.317, 2010.

D. Dodoo, F. Atuguba, S. Bosomprah, N. A. Ansah, P. Ansah et al., Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana, Malar J, vol.10, p.108, 2011.

G. G. Fouda, R. F. Leke, C. Long, P. Druilhe, A. Zhou et al., Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens, Clin Vaccine Immunol, vol.13, pp.1307-1313, 2006.

C. Proietti, F. Verra, M. T. Bretscher, W. Stone, B. N. Kanoi et al., Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda, Parasite Immunol, vol.35, pp.164-173, 2013.

S. Bonnet, S. Petres, I. Holm, T. Fontaine, S. Rosario et al., Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate, Vaccine, vol.24, pp.5997-6008, 2006.

I. Vigan-womas, M. Guillotte, A. Juillerat, C. Vallieres, A. Lewit-bentley et al., Mercereau-Puijalon O: Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes, PLoS ONE, vol.6, p.16544, 2011.

O. Garraud, S. Mahanty, and R. Perraut, Malaria-specific antibody subclasses in immune individuals: a key source of information for vaccine design, Trends Immunol, vol.24, pp.30-35, 2003.
URL : https://hal.archives-ouvertes.fr/pasteur-00566841

J. F. Trape and C. Rogier, Combating malaria morbidity and mortality by reducing transmission, Parasitol Today, vol.12, pp.236-240, 1996.

J. F. Trape, C. Rogier, L. Konate, N. Diagne, H. Bouganali et al., The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal, Am J Trop Med Hyg, vol.51, pp.123-137, 1994.

J. F. Trape, A. Tall, C. Sokhna, A. B. Ly, N. Diagne et al., The rise and fall of malaria in a west African rural community, vol.14, pp.476-488, 2014.

D. Fontenille, L. Lochouarn, M. Diatta, C. Sokhna, D. I. Diagne et al., Four years' entomological study of the transmission of seasonal malaria in Senegal and the bionomics of Anopheles gambiae and A. arabiensis, Trans R Soc Trop Med Hyg, vol.91, pp.647-652, 1997.

I. Vigan-womas, M. Guillotte, L. Scanf, C. Igonet, S. Petres et al., Mercereau-Puijalon O: An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype, Infect Immun, vol.76, pp.5565-5580, 2008.

R. Perraut, L. Marrama, B. Diouf, D. Fontenille, A. Tall et al., Distinct surrogate markers for protection against Plasmodium falciparum infection and clinical malaria identified in a Senegalese community after radical drug cure, J Infect Dis, vol.188, pp.1940-1950, 2003.
URL : https://hal.archives-ouvertes.fr/pasteur-00566835

D. R. Cavanagh, I. M. Elhassan, C. Roper, V. J. Robinson, H. Giha et al., A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan, J Immunol, vol.161, pp.347-359, 1998.

D. J. Conway, D. R. Cavanagh, K. Tanabe, C. Roper, Z. S. Mikes et al., A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses, Nat Med, vol.6, pp.689-692, 2000.

L. A. Da-silveira, M. L. Dorta, E. A. Kimura, A. M. Katzin, F. Kawamoto et al., Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region, Infect Immun, vol.67, pp.5906-5916, 1999.

L. Joergensen, L. Turner, P. Magistrado, M. A. Dahlback, L. S. Vestergaard et al., Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family, Infect Immun, vol.74, pp.6778-6784, 2006.

L. Joergensen, L. S. Vestergaard, L. Turner, P. Magistrado, J. P. Lusingu et al., 3D7-Derived Plasmodium falciparum erythrocyte membrane protein 1 is a frequent target of naturally acquired antibodies recognizing protein domains in a particular pattern independent of malaria transmission intensity, J Immunol, vol.178, pp.428-435, 2007.

K. A. Kusi, D. Dodoo, S. Bosomprah, M. Van-der-eijk, B. W. Faber et al., Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population, BMC Infect Dis, vol.12, p.32, 2012.

A. J. Nhabomba, C. Guinovart, A. Jimenez, M. N. Manaca, L. Quinto et al., Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique, Malar J, vol.13, p.121, 2014.

F. H. Osier, L. M. Murungi, G. Fegan, J. Tuju, K. K. Tetteh et al., Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria, Parasite Immunol, vol.32, pp.193-201, 2010.

C. Roussilhon, C. Oeuvray, C. Muller-graf, A. Tall, C. Rogier et al., Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3, PLoS Med, vol.4, p.320, 2007.

J. C. Gray, P. H. Corran, E. Mangia, M. W. Gaunt, Q. Li et al., Profiling the antibody immune response against blood stage malaria vaccine candidates, Clin Chem, vol.53, pp.1244-1253, 2007.

P. D. Crompton, M. A. Kayala, B. Traore, K. Kayentao, A. Ongoiba et al., A prospective analysis of the antibody response to Plasmodium falciparum before and after a malaria season by protein microarray, Proc Natl Acad Sci U S A, vol.107, pp.6958-6963, 2010.

G. K. Cham, J. Kurtis, J. Lusingu, T. G. Theander, A. T. Jensen et al., A semiautomated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma, Malar J, vol.7, p.108, 2008.

C. Fernandez-becerra, S. Sanz, M. Brucet, D. I. Stanisic, F. P. Alves et al., Naturally-acquired humoral immune responses against the N-and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay, Malar J, vol.9, p.29, 2010.

C. C. John, R. A. Donnell, P. O. Sumba, A. M. Moormann, T. F. De-koning-ward et al., Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa, J Immunol, vol.173, pp.666-672, 2004.

K. E. Persson, C. T. Lee, K. Marsh, and J. G. Beeson, Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies, J Clin Microbiol, vol.44, pp.1665-1673, 2006.

H. Bouharoun-tayoun, C. Oeuvray, F. Lunel, and P. Druilhe, Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages, J Exp Med, vol.182, pp.409-418, 1995.

C. Joos, L. Marrama, H. E. Polson, S. Corre, A. M. Diatta et al., Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies, PLoS ONE, vol.5, p.9871, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00494201

. Perraut, Comparative analysis of IgG responses to Plasmodium falciparum MSP1p19 and PF13-DBL1?1 using ELISA and a magnetic bead-based duplex assay (MAGPIX®-Luminex) in a Senegalese meso-endemic community, Malaria Journal, vol.13, p.410, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02937187